SPTBN2 and neoplasm: Similarly, an analysis of the Tumor Immune Evaluation Resource (TIMER) database showed that UCEC (64/531) and SKCM (40/468) had the highest mutation rates of SPTBN2 (Supplemental Fig. 1b).